文献速递脑血管病外科神经肿瘤

血清血管内皮生长因子与内皮抑素能否反映脑动静脉畸形立体定向放射外科后的放射性影像学改变

Do Serum Vascular Endothelial Growth Factor and Endostatin Reflect Radiological Radiation-Induced Changes After Stereotactic Radiosurgery for Cerebral Arteriovenous Malformations?
PubMed 文献 · World Neurosurg · 2019-03-02

本研究纳入27例接受立体定向放射外科治疗的脑动静脉畸形患者,于治疗前及治疗后1周、1个月、3个月、6个月检测血清血管内皮生长因子(VEGF)和内皮抑素,并每6个月进行临床与神经影像随访评估放射性影像学改变(RICs)。结果显示,发生RICs组(11例)放疗后6个月血清VEGF中位数58.98 pg/mL显著高于无RICs组(16例)的15.17 pg/mL(P=0.001);多因素分析显示放疗后6个月较高VEGF(P=0.001,HR 1.032,95%CI 1.012-1.052)和放疗后1个月较低内皮抑素(P=0.007,HR 0.964,95%CI 0.935-0.993)与RICs显著相关。作者认为系列检测血清VEGF和内皮抑素可能有助于预测接受SRS治疗的动静脉畸形患者的RICs。

要点

  • 发生RICs组放疗后6个月血清VEGF中位数58.98 pg/mL,显著高于无RICs组的15.17 pg/mL(P=0.001)。
  • 多因素分析显示放疗后6个月较高VEGF与RICs显著相关(P=0.001,HR 1.032,95%CI 1.012-1.052)。
  • 放疗后1个月较低内皮抑素与RICs显著相关(P=0.007,HR 0.964,95%CI 0.935-0.993)。

核心结论

  • 接受SRS治疗的脑动静脉畸形患者中,发生RICs组放疗后6个月血清VEGF水平高于无RICs组。
  • 放疗后6个月血清VEGF和放疗后1个月血清内皮抑素与放射性影像学改变相关。
  • 作者认为SRS后系列检测血清VEGF和内皮抑素可能有助于预测接受SRS治疗的动静脉畸形患者的RICs。

研究设计与样本

  • 研究共纳入27例接受立体定向放射外科(SRS)治疗的脑动静脉畸形患者,其中发生RICs组11例、无RICs组16例。
  • 于SRS前及SRS后1周、1个月、3个月、6个月采集外周静脉血检测血清生物标志物。
  • SRS后每6个月同期进行临床和神经影像随访以评估RICs。

主要发现

  • 血清VEGF与内皮抑素水平呈正相关(P=0.036,r=0.405)。
  • 发生RICs组SRS后6个月血清VEGF中位数为58.98 pg/mL,显著高于无RICs组的15.17 pg/mL(P=0.001)。
  • 多因素分析显示,SRS后6个月较高VEGF与RICs显著相关(P=0.001,HR 1.032,95%CI 1.012-1.052)。
  • 多因素分析显示,SRS后1个月较低内皮抑素与RICs显著相关(P=0.007,HR 0.964,95%CI 0.935-0.993)。

临床怎么用

  • 作者认为,SRS后系列检测血清VEGF和内皮抑素可能有助于预测接受SRS治疗的动静脉畸形患者的RICs。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to analyze serum levels of vascular endothelial growth factor (VEGF) and endostatin in patients with cerebral treated by stereotactic radiosurgery (SRS), and to assess their association with radiological radiation-induced changes (RICs). METHODS: To measure serum biomarkers, peripheral venous blood was collected before SRS and 1 week, 1 month, 3 months, and 6 months after SRS. To evaluate RICs, clinical and neuroimaging follow-up were performed concurrently every 6 months after SRS. RESULTS: Twenty-seven patients were enrolled (11 in the group with RIC, 16 in the group without RIC). Serum VEGF and endostatin levels were positively correlated (P = 0.036, r = 0.405). In the group with RIC, the median serum VEGF 6 months after SRS (58.98 pg/mL) was significantly higher than that of the group without RIC (15.17 pg/mL) (P = 0.001). Multivariate analysis revealed that higher VEGF 6 months after SRS (P = 0.001, hazard ratio, 1.032; 95% confidence interval, 1.012-1.052) and lower endostatin 1 month after SRS (P = 0.007, hazard ratio, 0.964; 95% confidence interval, 0.935-0.993) were significantly associated with RICs. CONCLUSIONS: Our results show that serum levels of VEGF 6 months after SRS were higher in the group with RIC. Serum levels of VEGF 6 months and endostatin 1 month after SRS were associated with the radiological RICs. Thus, serial measurements of serum VEGF and endostatin after SRS might help predict RICs in patients with arteriovenous malformation treated by SRS.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Lee JG, Park SH, Park KS, et al. Do Serum Vascular Endothelial Growth Factor and Endostatin Reflect Radiological Radiation-Induced Changes After Stereotactic Radiosurgery for Cerebral Arteriovenous Malformations? World Neurosurg. 2019. PMID: 30831282. doi:10.1016/j.wneu.2019.02.101

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。